Mark Zuckerberg and Priscilla Chan pledge $3 billion to treat disease, new rules require researchers to share clinical trial results, and neuroscientists unite for big brain projects.
A tie between first-trimester ultrasounds and autism severity is tenuous at best, misnamed genes litter the literature, and neuroscientists enjoy their version of summer camp.
Finding a difference between people with and without autism is only the first step toward identifying a clinically useful marker of the condition.
A new study casts doubt on the ‘extreme male brain’ theory of autism, Americans are worried about gene editing, and a Pasteur Institute clash raises questions about scientists’ age.
A new blood test could personalize depression treatment, a journalist dissects the demise of a large children’s study, and the National Institutes of Health budget may grow by $2 billion.
A training program leads physicians to screen more children for autism, psychotherapists may discriminate against the working class, and a lack of federal funding leaves children with autism underserved.